With just a few hours of trade left this week, the S&P/ASX 200 Index (ASX: XJO) is down 1.6% since last Friday’s closing bell, but that hasn’t held back these three surging ASX 200 stocks.
It’s a diversified list of top performers on my list for the week. One is a major energy supplier; one is a leading healthcare stock; and the third is a global metals and electronics recycler.
Here’s why they’ve been charging higher this week despite the broader market retrace.
ASX 200 stocks leaping higher this week
First up we have Sims Ltd (ASX: SGM).
Shares in the metals and electronics recycler closed last Friday trading for $18.36. At time of writing, shares are changing hands for $20.65. That sees this ASX 200 stock up 12.4% for the week.
Sims shares got a big boost on Wednesday after the company reported a positive FY 2026 trading update.
Noting continued price strength in both the non-ferrous and memory chip markets, Sims forecast full year underlying earnings before interest and tax (EBIT) to be between $350 million and $400 million.
Sims also reassured investors that the impact on its performance from the Middle East conflict to date remains relatively limited outside of shipping and fuel costs.
Moving on to the second ASX 200 stock racing higher in this week’s falling market, we have Viva Energy Group Ltd (ASX: VEA).
Shares in the oil refiner and fuel supplier closed last week trading for $2.14 and are currently changing hands for $2.42 each. This puts the Viva Energy share price up 13.3% for the week.
The stock has been a clear beneficiary of surging global oil and gas prices, with shares now up more than 37% over the past months.
Viva Energy also caught investor interest today following news of renewed Federal government support for domestic oil refining as the war in Iran threatens imports.
The government’s Fuel Security Services Payment (FSSP) provides financial support for Australia’s two remaining refineries when regional refining margins fall below long-term breakeven costs.
Viva Energy owns and operates the Geelong Refinery in Victoria.
Which brings us toâ¦
Leading the charge
The top performing ASX 200 stock on my list for today is Telix Pharmaceuticals Ltd (ASX: TLX).
Shares in the diagnostic and therapeutic product developer closed last Friday at $11.29. Shares are currently trading for $12.99 each. This sees the Telix share price up an impressive 14.7% in this week’s slumping market.
Telix shares look to have gotten a delayed boost throughout the week from Monday’s announcement that it had resubmitted a New Drug Application to the US Food and Drug Administration for its brain cancer imaging product TLX101-Px (Pixclara).
The resubmission included additional data requested by the FDA.
“Our resubmission is supported by an extensive and compelling data set â particularly so for an orphan indication,” Telix chief medical officer David Cade said.
The post 3 ASX 200 stocks screaming higher in this week’s sinking market appeared first on The Motley Fool Australia.
Should you invest $1,000 in Sims Metal Management Limited right now?
Before you buy Sims Metal Management Limited shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Sims Metal Management Limited wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 20 Feb 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- Up 38% in a month, ASX 200 energy share lifting off again Friday on big oil refining news
- Viva Energy welcomes government boost to refinery support
- Could Telix shares be a millionaire-maker stock?
- Here are the top 10 ASX 200 shares today
- 5 ASX 200 energy shares smash multi-year highs after oil price spike
Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Telix Pharmaceuticals. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.